ropinirole
Selected indexed studies
- Ropinirole. (, 2006) [PMID:30000578]
- Ropinirole, a New ALS Drug Candidate Developed Using iPSCs. (Trends Pharmacol Sci, 2020) [PMID:31926602]
- Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. (Cell Stem Cell, 2023) [PMID:37267913]
_Worker-drafted node — pending editorial review._
Connections
ropinirole is a side effect of
Sources
- Ropinirole. (2006) pubmed
- Ropinirole, a New ALS Drug Candidate Developed Using iPSCs. (2020) pubmed
- Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. (2023) pubmed
- Ropinirole silver nanocomposite attenuates neurodegeneration in the transgenic Drosophila melanogaster model of Parkinson's disease. (2020) pubmed
- Ropinirole therapy for Parkinson's disease. (2004) pubmed
- Ropinirole treatment for restless legs syndrome. (2008) pubmed
- Ropinirole for levodopa-induced complications in Parkinson's disease. (2000) pubmed
- Ropinirole: a dopamine agonist for the treatment of Parkinson's disease. (1999) pubmed
- Ropinirole: a review of its use in the management of Parkinson's disease. (2000) pubmed
- Clinical pharmacokinetics of ropinirole. (2000) pubmed